Notification report

Full notification file

General information

Notification Number

Member State to which the notification was sent

Date of acknowledgement from the Member State Competent Authority

Title of the Project
Vaccine candidate against Canine Visceral Leishmaniasis. Evaluation of efficacy by natural challenge in an experimental kennel.

Proposed period of release:
01/07/2010 to 31/08/2011

Name of the Institute(s) or Company(ies)
Merial, 29, Avenue Tony Garnier, 69007 Lyon, France;

3. Is the same GMO release planned elsewhere in the Community?

Has the same GMO been notified elsewhere by the same notifier?

GMO characterization

GMO is a:
DNA Virus

Identity of the GMO:
vCP2350 consisting of a recombinant canarypox virus expressing the KMP 11 antigen of Leishmania, under control of the H6 promoter from the vaccinia virus

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
CanarypoxvirusAvipoxvirusCanarypoxvirusALVAC clone

Final report

European Commission administrative information

Consent given by the Member State Competent Authority:
15/04/2010 00:00:00